Global Pharmacy Plus

Global Pharmacy Plus is an online prescription-drug sourcing and order facilitation business focused on helping customers obtain lower-cost brand and generic medicines through partner pharmacies in Europe, Asia, and North America. The company appears to operate primarily as an intermediary or agent rather than as a drug developer, manufacturer, or traditional dispensing pharmacy. Its business is commercial and service-oriented, centered on prescription fulfillment support, customer service, and cross-border medication access. Publicly available sources indicate the company has been active since 2012, but it has also been the subject of an FDA warning letter related to the online sale of unapproved and misbranded drugs to U.S. consumers. For biotech/pharma diligence purposes, this is best classified as a healthcare commerce business, not a therapeutic R&D company.